Peng et al. aimed to evaluate the expression and response of PD-1, TIM-3, LAG-3 after neo-adjuvant radiotherapy in rectal cancer and to evaluate the optimal treatment protocol with combined immunotherapy [39]. Here, PDCD1 is linked to rectal cancer.